SCHEMBL8024755

SCHEMBL8024755

Clc1ccc(-c2nc3ccccc3n2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.75
ESR1 P03372 2/20 0.65
ESR2 Q92731 2/20 0.65
KMT2A Q03164 4/20 0.64
MEN1 O00255 3/20 0.64
KDM4E B2RXH2 1/20 0.64
NPC1 O15118 1/20 0.64
LMNA P02545 1/20 0.64
RAB9A P51151 1/20 0.64
GRIA1 P42261 1/20 0.62
CACNG8 Q8WXS5 1/20 0.62
CACNG2 Q9Y698 1/20 0.62
AOC3 Q16853 4/20 0.60
KCNH2 Q12809 2/20 0.60
ALDH1A1 P00352 1/20 0.57
MAPKAPK2 P49137 1/20 0.56
HDAC1 Q13547 1/20 0.55
HDAC8 Q9BY41 1/20 0.55
HDAC6 Q9UBN7 1/20 0.55
HPGD P15428 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15481630 0.95 PTGS2 (0.70) PTGS2ESR1ESR2KMT2AMEN1
SCHEMBL8011006 0.95 ESR1 (0.72) PTGS2ESR1ESR2KMT2AMEN1
SCHEMBL8022202 0.95 PTGS2 (0.69) PTGS2ESR1ESR2KMT2AMEN1
SCHEMBL15481633 0.91 AOC3 (0.71) PTGS2ESR1ESR2KMT2AMEN1
SCHEMBL8011388 0.89 TP53 (0.66) PTGS2ESR1ESR2KMT2AMEN1
SCHEMBL804992 0.86 ESR2 (0.73) PTGS2ESR1ESR2KMT2AMEN1
SCHEMBL13231714 0.85 ESR2 (0.67) PTGS2ESR1ESR2KMT2AMEN1
SCHEMBL16692234 0.84 ESR2 (0.71) PTGS2ESR1ESR2KMT2AMEN1
SCHEMBL10041513 0.84 ESR2 (0.71) PTGS2ESR1ESR2KMT2AMEN1
SCHEMBL6440249 0.83 ESR2 (0.91) PTGS2ESR1ESR2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6030992-A ANTAGONISTS FOR THE BINDING OF NEUROKININ-2 RECEPTOR; SLEEP DISORDERS; BENZIMIDES, 2- OR 3-ALKOXYBENZIMIDES AND 2,3-DIALKOXYBENZIMIDES ELI LILLY AND COMPANY (US) 2000-02-29 US disclosed
US-6025379-A A SUBSTITUTED BENZIMIDAZOLE, TACHYKININ RECEPTOR ANTAGONISTS, ELI LILLY AND COMPANY (US) 2000-02-15 US disclosed
WO-1997031635-A1 METHODS OF TREATING OR PREVENTING SLEEP APNEA ELI LILLY AND COMPANY (US) 1997-09-04 WO disclosed
US-5552426-A NERVOUS SYSTEM DISORDERS USING IMIDAZOLE DERIVITIVES ELI LILLY AND COMPANY (US) 1996-09-03 US disclosed
EP-0694535-A1 Non-peptidyl tachykinin receptor antagonists ELI LILLY AND COMPANY (US) 1996-01-31 EP disclosed